. Instituto de Biotecnologia UNAM

IBT-UNAM : Dra. Hilda Vazquez Lopez.

Dra. Hilda Vazquez Lopez.

Investigador en estancia postdoctoral
Grupo del Dr. Alejandro Alagon

email: hvazquez @ibt.unam.mx
Teléfonos
Oficina +52 (777) 311-4900 ext 294

Laboratorio +52 (777) 329-1602
desde la CDMX 562-27602
red UNAM 27602
+52 (777) 311-4900 ext 294

Publicaciones recientes

Roman-Dominguez,L. Neri-Castro,E. Vazquez-Lopez,H. Garcia-Osorio,B. Archundia,I.G. Ortiz-Medina,J.A. Petricevich,V.L. Alagon,A. Benard-Valle,M. 2019. Biochemical and immunochemical characterization of venoms from snakes of the genus Agkistrodon Toxicon X, 4, 100013.

Diaz,P. Malave,C. Zerpa,N. Vazquez,H. D'Suze,G. Montero,Y. Castillo,C. Alagon,A. Sevcik,C. 2014. IgY pharmacokinetics in rabbits: Implications for IgY use as antivenoms Toxicon, 90, 124-133.

Vazquez,H. Olvera,F. Alagon,A. Sevcik,C. 2013. Production of anti-horse antibodies induced by IgG, F(ab') and Fab applied repeatedly to rabbits. Effect on antivenom pharmacokinetics Toxicon, 76, 362-369.

Sevcik,C. Salazar,V. Diaz,P. D'Suze,G. Vazquez,H. 2013. High resolution fluorescence microscopy evidence on the transport of immunoglobulins. Differences between mammalian IgG, F(ab')2 and avian IgY Toxicon, 63, 7-18 * .

Sevcik,C. D'Suze,G. Salazar,V. Diaz,P. Vazquez,H. 2012. Horse IgG- and ostrich IgY-F(ab')(2) groups have different affinities for mice erythrocytes and lymphocytes. Implications for avian immunoglobulin therapeutic usefulness Toxicon, 60, 1215-1221 * .

Vazquez,H. Chavez-Haro,A. Garcia-Ubbelohde,W. Paniagua-Solis,J. Alagon,A. Sevcik,C. 2010. Pharmacokinetics of a F(ab')(2) scorpion antivenom administered intramuscularly in healthy human volunteers International Immunopharmacology, 10, 1318-1324.

Vazquez,H. Olvera,F. Paniagua-Solis,J. Alagon,A. Sevcik,C. 2010. Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab')2, IgG and IgG(T) fragments from hyper immune equine plasma International Immunopharmacology, 10, 447-454.

Chase,P. Boyer-Hassen,L. McNally,J. Vazquez,H.L. Theodorou,A.A. Walter,F.G. Alagon,A. 2009. Serum levels and urine detection of Centruroides sculpturatus venom in significantly envenomated patients Clinical Toxicology, 47, 24-28.

Dragulev,B. Bao,Y. Ramos-Cerrillo,B. Vazquez,H. Olvera,A. Stock,R.P. Alagon,A. Fox,J.W. 2007. Upregulation of cytokine expression in fibroblasts exposed to Loxosceles sphingomyelinase D: What is the trigger? Journal of Investigative Dermatology, 127, 1267-1268.

Dragulev,B. Bao,Y. Ramos-Cerrillo,B. Vazquez,H. Olvera,A. Stock,R. Algaron,A. Fox,J.W. 2007. Upregulation of IL-6, IL-8, CXCL1, and CXCL2 Dominates Gene Expression in Human Fibroblast Cells Exposed to Loxosceles reclusa Sphingomyelinase D: Insights into Spider Venom Dermonecrosis Journal of Investigative Dermatology, 127, 1264-1266.

Olvera,A. Ramos-Cerrillo,B. Estevez,J. Clement,H. de Roodt,A. Paniagua-Solis,J. Vazquez,H. Zavaleta,A. Salas-Arruz,M. Stock,R.P. Alagon,A. 2006. North and South American Loxosceles spiders: Development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens Toxicon, 48, 64-74.

Vazquez,H. Chavez-Haro,A. Garcia-Ubbelohde,W. Mancilla-Nava,R. Paniagua-Solis,J. Alagon,A. Sevcik,C. 2005. Pharmacokinetics of a F(ab')(2) scorpion antivenom in healthy human volunteers Toxicon, 46, 797-805.

* Indica publicación con otra institución de adscripción